Cite

HARVARD Citation

    Gamerith, G. et al. (n.d.). Soluble immune checkpoints CD27, Lag3, PD-L2 and Tim3 in early stage NSCLC patients. European journal of cancer. pp. S12-. [Online]. 
  
Back to record